Table 1.
Demographic and clinical characteristics in the case and control groups
| GAD (n=102) | HC (n=120) | χ2/t | P | |
|---|---|---|---|---|
| Sex (male/female) | 22/80 | 26/94 | 0.000 | 1.000* |
| Age (years) | 48.41±11.15 | 36.15±8.17 | 5.693 | 0.018# |
| Age of onset (years) | 42.95±12.03 | NA | ||
| Family history of SAD | 23 (22.5%) | NA | ||
| HAMA scale (baseline) | 22.50±3.52 | NA | ||
| HAMD scale (baseline) | 14.28±2.64 | NA | ||
| Escitalopram, n (%) | 59 (57.8) | NA | ||
| Venlafaxine, n (%) | 43 (42.2) | NA |
*
p Value was obtained using chi-squared tests.
#
p Value was obtained using two sample t-tests.
GAD, generalized anxiety disorder; HC HAM-A, Hamilton Rating Scale for Anxiety at baseline; HAM-D, Hamilton Rating Scale for Depression at baseline; NA, not applicable.